Letter to the Editor: Reply (HEP-19-1537 and 19-1551).
We agree that antiviral treatment affects outcomes in chronic hepatitis B (CHB) patients. In our study, antiviral therapy use was only significant in univariable analysis, but did not reach significance in the multivariable model for clinical events (p=0.134). Addition of antiviral treatment to the selected model did not reach significance (p=0.127) and had no effect on the hazard ratios of other variables.